CN Patent

CN113825529A — 充气微泡

Assigned to Bracco Suisse SA · Expires 2021-12-21 · 4y expired

What this patent protects

特别用于制备稳定充气微泡的脂质制剂，包含具有有利的相对摩尔比的二硬脂酰磷脂酰胆碱(DSPC)、二棕榈酰磷脂酰乙醇胺‑PEG5000(DPPE‑PEG5000)和棕榈酸。该制剂特别适用于使用超声波的治疗应用。

USPTO Abstract

特别用于制备稳定充气微泡的脂质制剂，包含具有有利的相对摩尔比的二硬脂酰磷脂酰胆碱(DSPC)、二棕榈酰磷脂酰乙醇胺‑PEG5000(DPPE‑PEG5000)和棕榈酸。该制剂特别适用于使用超声波的治疗应用。

Drugs covered by this patent

sulfur-hexafluoride-lipid-type-a-microspheres (Sulfur hexafluoride lipid-type A microspheres) · Children's Hospital of Philadelphia

Patent Metadata

Patent number: CN113825529A
Jurisdiction: CN
Classification: —
Expires: 2021-12-21
Drug substance claim: No
Drug product claim: No
Assignee: Bracco Suisse SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.